A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region

Genomics

Volumn 49, Issue 3, 1998, Pages 351-362

  Bench, Anthony J ^a   Aldred, Micheala A ^a   Humphray, Sean J ^b   Champion, Kim M ^a   Gilbert, James G R ^a   Asimakopoulos, Fotios A ^a   Deloukas, Panos ^b   Gwilliam, Rhian ^b   Bentley, David R ^b   Green, Anthony R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MARKER;

ARTICLE; CELL SUBPOPULATION; CENTROMERE; CHROMOSOME 20P; CHROMOSOME MAP; CLINICAL ARTICLE; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031832935     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5231     Document Type: Article

References (95)

1. Aitken A. 14-3-3 and its possible role in co-ordinating multiple signaling pathways. Trends Cell Biol. 6:1996;341-347.
2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Anand R., Riley J. H., Butler R., Smith J. O., Markham F. A 3.5 genome equivalent multi access YAC library: Construction, characterisation, screening and storage. Nucleic Acids Res. 18:1990;1951-1956.
4. Asimakopoulos F. A., Gilbert J. G. R., Aldred M. A., Pearson T. C., Green A. R. Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood. 88:1996a;2690-2698.
5. Asimakopoulos F. A., Green A. R. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br. J. Haematol. 95:1996;219-226.
6. Asimakopoulos F. A., Holloway T. L., Nacheva E. P., Scott M. A., Fenaux P., Green A. R. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood. 87:1996b;1561-1570.
7. Asimakopoulos F. A., White N. J., Nacheva E., Green A. R. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodyslastic syndromes. Blood. 84:1994;3086-3094.
8. Asimakopoulos F. A., White N. J., Nacheva E. P., Green A. R. The humanCD40. Br. J. Haematol. 92:1996c;127-130.
9. Avraham K. B., Prezioso V. R., Chen W. S., Lai E., Sladek F. M., Zhong W., Darnell J. E. J., Jenkins N. A., Copeland N. G. Murine chromosomal location of four hepatocyte enriched transcription factors: HNF-3α, HNF-3β, HNF-3γ, and HNF-4. Genomics. 13:1992;264-268.
10. Bentley D. R., Todd C., Collins J., Holland J., Dunham I., Hassock S., Bankier A., Giannelli F. The development and application of automated gridding for efficient screening of yeast and bacterial ordered libraries. Genomics. 12:1992;534-541.
11. Bernardi G. The isochore organization of the human genome. Annu. Rev. Genet. 23:1989;637-661.
12. Bernardi G. The isochore organization of the human genome and its evolutionary history - A review. Gene. 135:1993;57-66.
13. Boultwood J., Rack K., Kelly S., Madden J., Sakaguchi A. Y., Wang L. M., Oscier D. G., Buckle V. J., Wainscoat J. S. Loss of bothCSF1RFMS. Proc. Natl. Acad. Sci. USA. 88:1991;6176-6180.
14. Bowden D. W., Krawchuk M. D., Weaver E. J., Howard T. D., Knowlton R. G., Rao P. N., Pettenati M. J., Hayworth R., Wagner B. J., Rothschild C. B. D20S16 is a complex interspersed repeated sequence: Genetic and physical analysis of the locus. Genomics. 25:1995;394-403.
15. Braselmann S., McCormick F. BCR and RAF form a complexin vivo. EMBO J. 14:1995;4839-4848.
16. Bristol A., Hall S. M., Kriz R. W., Stahl M. L., Fan Y. S., Byers M. G., Eddy R. L., Shows T. B., Knopf J. L. Phospholipase C-148: Chromosomal location and deletion mapping of functional domains. Cold Spring Harb. Symp. Quant. Biol. 53:1988;915-920.
17. Brown A. G., Ross F. M., Dunne E. M., Steel C. M., Weir-Thompson E. M. Evidence for a new tumour suppressor locus (DBM. Nat. Genet. 3:1993;67-72.
18. Buetow K. H., Weber J. L., Ludwigsen S., Scherpbier-Heddema T., Duyk G. M., Sheffield V. C., Wang Z., Murray J. C. Integrated human genome-wide maps constructed using the CEPH reference panel. Nat. Genet. 6:1994;391-393.
19. Cairns P., Polascik T. J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W., Rutter J. L., Buckler A., Gabrielson E., Tockman M., Cho K. R., Hedrick L., Bova G. S., Isaacs W., Koch W., Schwab D., Sidransky D. Frequency of homozygous deletion atp16CDKN2. Nat. Genet. 11:1995;210-212.
20. Cayuela J. M., Madani A., Sanhes L., Stern M. H., Sigaux F. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood. 87:1996;2180-2186.
21. Chapman R. M., Corcoran M. M., Gardiner A., Hawthorn L. A., Cowell J. K., Oscier D. G. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene. 9:1994;1289-1293.
22. Chartier F. L., Bossu J. P., Laudet V., Fruchart J. C., Laine B. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene. 147:1994;269-272.
23. Chumakov I. M., Le Gall I., Billaut A., Ougen P., Guillou S., Rigault P., Bui H., De Tand M.-F., Barillot E., Abderrahim H., Cherif D., Berger R., Le Palier D., Cohen D. Isolation of chromosome 21-specific yeast artificial chromosomes from a total human genome library. Nature. 359:1992;380-386.
24. Coffey A., Gregory S., Cole C. G. Alu. YAC Protocols. 1996;Humana Press, Totowa. p. 97-114.
25. Cole C. G., Collins J. E., Dunham I. YAC library screening. Markie D. YAC Protocols. 1996;23-47 Humana Press, Totowa.
26. Company M., Arenas J., Abelson J. Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes. Nature. 349:1991;487-493.
27. Cordes S. P., Barsh G. S. The mouse segmentation genekr. Cell. 79:1994;1025-1034.
28. Creasy C. L., Chernoff J. Cloning and characterization of a human protein kinase with homology to Ste20. J. Biol. Chem. 270:1995;21695-21700.
29. Daddona P. E., Shewach D. S., Kelley W. N., Argos P., Markham A. F., Orkin S. H. Human adenosine deaminase: cDNA and complete primary amino acid sequence. J. Biol. Chem. 259:1984;2101-2106.
30. DeBry R. W., Seldin M. F. Human/mouse homology relationships. Genomics. 33:1996;337-351.
31. Demory J. L., Dupriez B., Fenaux P., Laï J. L., Beuscart R., Jouet J. P., Deminatti M., Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases. Blood. 72:1988;855-859.
32. Dewald G. W., Schad C. R., Lilla V. C., Jalal S. M. Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. Cancer Genet. Cytogenet. 68:1993;60-69.
33. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E., Lathrop M., Gyapay G., Morissette J., Weissenbach J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 380:1996;152-154.
34. Diez-Martin J. L., Graham D. L., Petitt R. M., Dewald G. W. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin. Proc. 66:1991;287-299.
35. Eichmann A., Grapin-Botton A., Kelly L., Graf T., LeDouarin N. M., Sieweke M. The expression pattern of themafBkrkreisler. Mech. Dev. 65:1997;111-122.
36. Gish W., States D. J. Identification of protein coding regions by database similarity search. Nat. Genet. 3:1993;266-272.
37. Grange T., Martins de Sa C., Oddos J., Pictet R. Human mRNA polyadenylate binding protein: Evolutionary conservation of a nucleic acid binding motif. Nucleic Acids Res. 15:1987;4771-4787.
38. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat. Genet. 7:1994;246-339.
39. Hirama T., Koeffler H. P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 86:1995;841-854.
40. Hollings P. E. Molecular heterogeneity at the breakpoints of smaller 20q deletions. Genes Chromosomes Cancer. 11:1994;21-28.
41. Ioannou P. A., Amemiya C. T., Garnes J., Kroisel P. M., Shizuya H., Chen C., Batzer M. A., de Jong P. J. A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nat. Genet. 6:1994;84-89.
42. Jay P., Diriong S., Taviaux S., Roeckel N., Mattéi M. G., Audit M., Bérge-Lefranc J.-L., Fontès M., Berta P. Isolation and regional mapping of cDNAs expressed during early human development. Genomics. 39:1997;104-108.
43. Jotterand Bellomo M., Parlier V., Schmidt P. M., Beris P. Cytogenetic analysis of 54 cases of myelodysplastic syndrome. Cancer Genet. Cytogenet. 46:1990;157-172.
44. Kataoka K., Fujiwara K. T., Noda M., Nishizawa M. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol. Cell. Biol. 14:1994;7581-7591.
45. Knapp R. H., Dewald G. W., Pierre R. V. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin. Proc. 60:1985;507-516.
46. Kritis A. A., Argyrokastritis A., Moschonas N. K., Power S., Katrakili N., Zannis V. I., Cereghini S., Talianidis I. Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene. 173:1996;275-280.
47. Kurtin P. J., Dewald G. W., Shields D. J., Hanson C. A. Hematologic disorders associated with deletions of chromosome 20q. Am. J. Clin. Pathol. 106:1996;680-688.
48. Lafage-Pochitaloff M., Herman P., Birg F., Galizzi J. P., Simonetti J., Mannoni P., Banchereau J. Localization of the humanCD40. Leukemia. 8:1994;1172-1175.
49. Lander E. S., Green P. Construction of multilocus genetic linkage maps in humans. Proc. Natl. Acad. Sci. USA. 84:1987;2363-2367.
50. Larin Z., Monaco A. P., Lehrach H. Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. Proc. Natl. Acad. Sci. USA. 88:1991;4123-4127.
51. 1. Proc. Natl. Acad. Sci. USA. 91:1994;10079-10083.
52. Liu Y., Szekely L., Grandér D., Söderhäll S., Juliusson G., Gahrton G., Linder S., Einhorn S. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intactRB1. Proc. Natl. Acad. Sci. USA. 90:1993;8697-8701.
53. Matise T. C., Perlin M., Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): A human genome linkage map. Nat. Genet. 6:1994;384-390.
54. Mertens F., Johansson B., Heim S., Kristoffersson U., Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: Report on 74 cases and review of the literature. Leukemia. 5:1991;214-220.
55. Miller J. B., Testa J. R., Lindgren V., Rowley J. D. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer. 55:1985;582-591.
56. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet. 15:1997;417-474.
57. Molhuizen H. O. F., Alkemade H. A. C., Zeeuwen P. L. J. M., de Jongh G. J., Wieringa B., Schalkwijk J. SKALP/Elafin: An elastase inhibitor from cultured human keratinocytes. J. Biol. Chem. 268:1993;12028-12032.
58. Morrish D. W., Dakour J., Li H. Cloning of PL33: A novel probable serpentine membrane receptor associated with human cytotrophoblast and lineage-specific HL-60 cell differentiation. Mol. Cell. Endocrinol. 120:1996;147-151.
59. Mufti G. J. Chromosomal deletions in the myelodysplastic syndrome. Leuk. Res. 16:1992;35-41.
60. Noben-Trauth K., Copeland N. G., Gilbert D. J., Jenkins N. A., Sonoda G., Testa J. R., Klempnauer K. H. Mybl2Bmyb. Genomics. 35:1996;610-612.
61. Nomura N., Takahashi M., Matsui M., Ishii S., Date T., Sasamoto S., Ishizaki R. Isolation of human cDNA clones ofmybmybmyb. Nucleic Acids Res. 16:1988;11075-11089.
62. Olsen S. R., Uhler M. D. Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase. J. Biol. Chem. 266:1991;11158-11162.
63. Parlier V., van Melle G., Beris P., Schmidt P. M., Tobler A., Haller E., Jotterand Bellomo M. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Cancer Genet. Cytogenet. 78:1994;219-231.
64. Perkins D., Brennan S., Carstairs K., Bailey D., Pantalony D., Poon A., Fernandes B., Dubé I. Regional cancer cytogenetics: A report on 1,143 diagnostic cases. Cancer Genet. Cytogenet. 96:1997;64-80.
65. Ragoussis J. Restriction analysis of YACs. Markie D. YAC Protocols. 1996;69-74 Humana Press, Totowa.
66. Rapp G., Freudenstein J., Klaudiny J., Mucha J., Wempe F., Zimmer M., Scheit K. H. Characterization of three abundant mRNAs from human ovarian granulosa cells. DNA Cell Biol. 9:1990;479-485.
67. Rege-Cambrin G., Mecucci C., Tricot G., Michaux J.-L., Louwagie A., Van Hove W., Francart H., Van den Bergh H. A chromosomal profile of polycythemia vera. Cancer Genet. Cytogenet. 25:1987;233-245.
68. Reilly J. T., Snowden J. A., Spearing R. L., Fitzgerald P. M., Jones N., Watmore A., Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases. Br. J. Haematol. 98:1997;96-102.
69. Riley J., Butler R., Ogilvie D., Finniear R., Jenner D., Powell S., Anand R., Smith J. C., Markham A. F. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res. 18:1990;2887-2890.
70. Rossi F., Labourier E., Forné T., Divita G., Derancourt J., Riou J. F., Antoine E., Cathala G., Brunel C., Tazi J. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature. 381:1996;80-82.
71. Rothschild C. B., Akots G., Hayworth R., Pettenati M. J., Rao P. N., Wood P., Stolz F. M., Hansmann I., Serino K., Keith T. P., Fajans S. S., Bowden D. W. A genetic map of chromosome 20q12-q13.1: Multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus. Am. J. Hum. Genet. 52:1993;110-123.
72. Roulston D., Espinosa R. III, Stoffel M., Bell G. I., Le Beau M. M. Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood. 82:1993;3424-3429.
73. Sakai M., Imaki J., Yoshida K., Ogata A., Matsushima-Hibaya Y., Kuboki Y., Nishizawa M., Nishi S. Ratmaf. Oncogene. 14:1997;745-750.
74. Sala A., Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation ofcdc2. Proc. Natl. Acad. Sci. USA. 89:1992;10415-10419.
75. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
76. Schlessinger J. Phospholipase Cγ activation and phosphoinositide hydrolysis are essential for embryonal development. Proc. Natl. Acad. Sci. USA. 94:1997;2798-2799.
77. Screaton G. R., Cáceres J. F., Mayeda A., Bell M. V., Plebanski M., Jackson D. G., Bell J. I., Krainer A. R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:1995;4336-4349.
78. Sieweke M. H., Tekotte H., Frampton J., Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell. 85:1996;49-60.
79. Sladek F. M., Zhong W. M., Lai E., Darnell J. E. Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:1990;2353-2365.
80. Spring J., Goldberger O. A., Jenkins N. A., Gilbert D. J., Copeland N. G., Bernfield M. Mapping of the syndecan genes in the mouse: Linkage with members of theMyc. Genomics. 21:1994;597-601.
81. Stamenkovic I., Clark E. A., Seed B. A B-lymbphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1989;1403-1410.
82. Stoffel M., Le Beau M. M., Espinosa R. III, Bohlander S. F., Le Paslier D., Cohen D., Xiang K. S., Cox N. J., Fajans S. S., Bell G. I. A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene,MODY1, Proc. Natl. Acad. Sci. USA. 93:1996;3937-3941.
83. Stokke T., Collins C., Kuo W. L., Kowbel D., Shadravan F., Tanner M., Kallioniemi A., Kallioniemi O. P., Pinkel D., Deaven L., Gray J. W. A physical map of chromosome 20 established using fluorescencein situ. Genomics. 26:1995;134-137.
84. Swolin B., Weinfeld A., Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood. 72:1988;386-395.
85. Taylor L. K., Wang H. C. R., Erikson R. L. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proc. Natl. Acad. Sci. USA. 93:1996;10099-10104.
86. Testa J. R., Kanofsky J. R., Rowley J. D., Baron J. M., Vardiman J. W. Karyotypic patterns and their clinical significance in polycythemia vera. Am. J. Hematol. 11:1981;29-45.
87. Tommerup N., Leffers H. Assignment of the human genes encoding 14-3-3 Eta (YWHAHYWHAZYWHABin situ. Genomics. 33:1996;149-150.
88. Ulvsbäck M., Lazure C., Lilja H., Spurr N. K., Rao V. V. N. G., Löffler C., Hansmann I., Lundwall Å. Gene structure of semenogelin I and II. J. Biol. Chem. 267:1992;18080-18084.
89. Van Patten S. M., Howard P., Walsh D. A., Maurer R. A. The α- and β-isoforms of the inhibitor protein of the 3′,5′-cyclic adenosine monophosphate-dependent protein kinase: Characteristics and tissue- and developmental-specific expression. Mol. Endocrinol. 6:1992;2114-2122.
90. Wang J. C. DNA topoisomerases. Annu. Rev. Biochem. 54:1985;665-697.
91. Wang J. C., Caron P. R., Kim R. A. The role of DNA topoisomerases in recombination and genome stability: A double-edged sword. Cell. 62:1990;403-406.
92. Wang P. W., Iannantuoni K., Stoffel M., Le Beau M. M. Refinement of the commonly deleted segment of chromosome 20 in myeloid leukaemias with a del(20q). Blood. 88:1996;246.
93. White N. J., Nacheva E., Asimakopoulos F. A., Bloxham D., Paul B., Green A. R. Deletion of chromosome 20q in myelodysplasia occurring in multipotent precursor of both myeloid cells and B cells. Blood. 83:1994;2809-2816.
94. Williamson C. M., Dutton E. R., Beechey C. V., Peters J. Protective protein for β-galactosidase,Ppgb, Genomics. 22:1994;240-242.
95. Wunderle V., Dib C., Fizames C., Morisette J., Hazan J., Hansmann I., Whitehouse D., Vergnaud G., Weissenbach J. The EUROGEM map of human chromosome 20. Eur. J. Hum. Genet. 2:1994;242-243.